Inventor · disambiguated record
Bruce Beutler
Also filed as: BEUTLER BRUCE · BEUTLER BRUCE A
18 granted patents·14 pending applications·796 citations·filing 1992–2025
94Inventor score
Files withUNIV TEXAS12UNIV ROCKEFELLER9SCRIPPS RESEARCH INST7BEUTLER BRUCE3TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN1
Top patents by PatentIndex Score
32 records- 0193US5447851ADNA encoding a chimeric polypeptide comprising the extracellular domain of TNF receptor fused to IgG, vectors, and host cellsUNIV TEXAS·Filed 1992·Granted Sep 5, 1995·672 cites·25 claims
- 0281US5616688AMacrophage-derived inflammatory mediator (MIP-1α and MIP-1β)UNIV ROCKEFELLER·Filed 1994·Granted Apr 1, 1997·33 cites·15 claims
- 0376US2024233881A1Systems and methods for dispersion of molecules in mixturesUNIV TEXAS·Filed 2024·Application pending·0 cites
- 0474US9649373B2Neoseptins: small molecule adjuvantsSCRIPPS RESEARCH INST·Filed 2014·Granted May 16, 2017·1 cites·14 claims
- 0573US9918959B2TLR-independent small molecule adjuvantsSCRIPPS RESEARCH INST·Filed 2015·Granted Mar 20, 2018·1 cites·15 claims
- 0669US7029861B1LPS-response gene compositions and methodsUNIV TEXAS·Filed 1999·Granted Apr 18, 2006·18 cites·26 claims
- 0765US2025378910A1Systems and methods to identify mutation and phenotype associationUNIV TEXAS·Filed 2023·Application pending·0 cites
- 0864US2025367166A1Next generation diprovocims that activate the innate and adaptive immune responseSCRIPPS RESEARCH INST·Filed 2023·Application pending·0 cites
- 0960US2022162303A1Compositions and methods for cancer therapyUNIV TEXAS·Filed 2022·Application pending·0 cites
- 1059US11365250B2Compositions and methods for cancer therapyUNIV TEXAS·Filed 2018·Granted Jun 21, 2022·0 cites·17 claims
- 1159US5817763AMacrophage-derived inflammatory mediator (MIP-1α and MIP-1β)UNIV ROCKEFELLER·Filed 1995·Granted Oct 6, 1998·6 cites·9 claims
- 1258US5925548AModified receptors that continuously signalUNIV TEXAS·Filed 1996·Granted Jul 20, 1999·14 cites·16 claims
- 1356US2024043838A1Compositions targeting wdr37 and methods of use thereofUNIV TEXAS·Filed 2021·Application pending·0 cites
- 1455US5989836AMethod for measuring the binding sites for macrophage-derived inflammatory mediator (MIP-1α and MIP-1β)UNIV ROCKEFELLER·Filed 1995·Granted Nov 23, 1999·5 cites·6 claims
- 1555US2023416740A1Compositions targeting pacs1 and methods of use thereofUNIV TEXAS·Filed 2021·Application pending·0 cites
- 1654US6019969AComposition comprising antibody to macrophage-derived inflammatory mediator (MIP-α 1 and MIP-1β)UNIV ROCKEFELLER·Filed 1995·Granted Feb 1, 2000·9 cites·14 claims
- 1753US2021315992A1Adjuvant effect of the tlr1/2 agonist diprovocim synergizes with checkpoint-inhibiting antibodies to eliminate diseaseUNIV TEXAS·Filed 2019·Application pending·0 cites
- 1852US2009202519A1Compositions and methods for treating gram positive bacterial infection in a mammalian subjectSCRIPPS RESEARCH INST·Filed 2006·Application pending·0 cites
- 1950US6046309AMacrophage-derived inflammatory mediator (MIP-1α and MIP-1β)UNIV ROCKEFELLER·Filed 1995·Granted Apr 4, 2000·8 cites·22 claims
- 2050US5760186AAntibody to macrophage-derived inflammatory mediator (MIP-1α and MIP-1β)UNIV ROCKEFELLER·Filed 1995·Granted Jun 2, 1998·4 cites·15 claims
- 2148US5863535AMacrophage-derived inflammatory mediator (MIP-1α and MIP-1β)UNIV ROCKEFELLER·Filed 1995·Granted Jan 26, 1999·4 cites·16 claims
- 2247US5770402ADNA encoding macrophage inflammatory protein-1γUNIV TEXAS·Filed 1995·Granted Jun 23, 1998·12 cites·30 claims
- 2347US2025228977A1Compositions and Methods for Treating Striatonigral DegenerationTEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN·Filed 2025·Application pending·0 cites
- 2444US5849873AMacrophage-derived inflammatory mediator (MIP-1 α and MIP-1 β)UNIV ROCKEFELLER·Filed 1995·Granted Dec 15, 1998·4 cites·9 claims
- 2543US7705199B2Compositions and methods for treatment of autoimmune and related diseasesSCRIPPS RESEARCH INST·Filed 2006·Granted Apr 27, 2010·0 cites·14 claims
- 2643US2021269519A1Methods and Compositions for Regulating an Immune ResponseUNIV TEXAS·Filed 2019·Application pending·0 cites
- 2742US11040959B2Diprovocims: a new and potent class of TLR agonistsSCRIPPS RESEARCH INST·Filed 2017·Granted Jun 22, 2021·0 cites·16 claims
- 2840US2007231335A1Compositions and methods for treating Gram positive bacterial infection in a mammalian subjectBEUTLER BRUCE·Filed 2006·Application pending·0 cites
- 2939US2011214194A1Compositions and methods for modulating cells via cd14 and toll-like receptor 4 signaling pathwayBEUTLER BRUCE·Filed 2006·Application pending·0 cites
- 3039US2006257411A1Compositions and methods for modulating cells via CD14 and toll-like receptor 4 signaling pathwayBEUTLER BRUCE·Filed 2006·Application pending·0 cites
- 3138US5741484AMacrophage-derived inflammatory mediator (MIP-1α and MIP-1β)UNIV ROCKEFELLER·Filed 1995·Granted Apr 21, 1998·5 cites·9 claims
- 3237US2007243575A1Compositions and methods for treatment of immune-related diseaseSCRIPPS RESEARCH INST·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bruce Beutler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →